| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.
|
N Engl J Med
|
2003
|
16.62
|
|
2
|
Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation.
|
J Immunol
|
2002
|
5.10
|
|
3
|
Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB.
|
Nat Biotechnol
|
2002
|
3.43
|
|
4
|
Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine.
|
J Infect Dis
|
2003
|
2.02
|
|
5
|
Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection.
|
Nat Med
|
2002
|
1.93
|
|
6
|
Safety and immunogenicity profile of the concomitant administration of ZOSTAVAX and inactivated influenza vaccine in adults aged 50 and older.
|
J Am Geriatr Soc
|
2007
|
1.42
|
|
7
|
A double-blind, randomized, controlled, multicenter safety and immunogenicity study of a refrigerator-stable formulation of Zostavax.
|
Clin Vaccine Immunol
|
2007
|
1.25
|
|
8
|
Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster.
|
Vaccine
|
2010
|
1.04
|
|
9
|
Extensive replicative capacity of human central memory T cells.
|
J Immunol
|
2004
|
1.02
|
|
10
|
A tumor-associated glycoprotein that blocks MHC class II-dependent antigen presentation by dendritic cells.
|
J Immunol
|
2004
|
0.97
|
|
11
|
Comparison of the levels of immunogenicity and safety of Zostavax in adults 50 to 59 years old and in adults 60 years old or older.
|
Clin Vaccine Immunol
|
2009
|
0.96
|
|
12
|
Efficient transduction of human monocyte-derived dendritic cells by chimpanzee-derived adenoviral vector.
|
Hum Gene Ther
|
2003
|
0.93
|
|
13
|
Safety, tolerability, and immunogenicity of a two-dose regimen of high-titer varicella vaccine in subjects > or =13 years of age.
|
Vaccine
|
2006
|
0.88
|
|
14
|
Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults ≥60 years of age.
|
Vaccine
|
2011
|
0.88
|
|
15
|
Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma.
|
Clin Cancer Res
|
2003
|
0.88
|
|
16
|
Immune reconstitution following autologous transfers of CD3/CD28 stimulated CD4(+) T cells to HIV-infected persons.
|
Clin Immunol
|
2004
|
0.86
|
|
17
|
Tumor-associated macrophages as a source of functional dendritic cells in ovarian cancer patients.
|
Clin Immunol
|
2002
|
0.77
|